Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease
NCT00391898Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of entacapone in Parkinson's disease (PD) (2 arms), sponsored by Novartis. Primary endpoint: Unified Parkinson's Disease Rating Scale Part II (Activities of Daily Living) at Month 3. Started Oct 2006; status: completed.
02
Drugs
entacapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00391898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391898.